Efficacy and acceptability of early mifepristone-misoprostol medical abortion in Ukraine: Results of two clinical trials

REFERENCES

• International Consortium for Medical Abortion: ICMA Publications [Internet]. Countries abortion profile: Ukraine. Chisinau, Moldova: ICMA. Accessed 10 November 2012 from: http://www.medicalabortionconsortium.org/country/UA/.
   Google Scholar
• Ukraine Ministry of Health. Ministry of Health annual statistical report 2010.
   Google Scholar
• Levchuk N, Perelli-Harris B. Declining fertility in Ukraine: What is the role of abortion and contraception? Rostock, Germany: Max Planck Institute for Demographic Research 2009. MPIDR Working Paper No.: WP-2009-045.
   Google Scholar
• Hajri S, Blum J, Gueddana N, . Expanding medical abortion in Tunisia: Women's experiences from a multi-site expansion study. Contraception 2004;70: 487–91.
   PubMed Web of Science ®Google Scholar
• Karki C, Pokharel H, Kushwaha A, . Acceptability and feasibility of medical abortion in Nepal. Int J Gynaecol Obstet 2009;106:39–42.
   PubMed Web of Science ®Google Scholar
• Shannon C, Wiebe E, Jacot F, . Regimens of misoprostol with mifepristone for early medical abortion: A randomised trial. BJOG 2006;113:621–8.
   PubMed Web of Science ®Google Scholar
• Bracken H, Gliozheni O, Kati K, . Medical Abortion Research Group. Mifepristone medical abortion in Albania: Results from a pilot clinical research study. Eur J Contracept Reprod Health Care 2006;11:38–46.
   Google Scholar
• Dahiya K, Mann S, Nanda S. Randomized trial of oral versus sublingual misoprostol 24 h after mifepristone for medical abortion. Arch Gynecol Obstet 2011; 284:59–63.
   PubMed Web of Science ®Google Scholar
• Raghavan S, Comendant R, Digol I, . Two-pill regimens of misoprostol after mifepristone medical abortion through 63 days’ gestational age: A randomized controlled trial of sublingual and oral misoprostol. Contraception 2009;79:84–90.
   PubMed Web of Science ®Google Scholar
• Ngoc NT, Nhan VQ, Blum J, . Is home-based administration of prostaglandin safe and feasible for medical abortion?Results from a multisite study in Vietnam. BJOG 2004;111:814–9.
   Google Scholar
• Bracken H; Family Planning Association of India (FPAI); Gynuity Health Projects Research Group for Simplifying Medical Abortion in India. Home administration of misoprostol for early medical abortion in India. Int J Gynaecol Obstet 2010;108:228–32.
   PubMedGoogle Scholar
• Boersma AA, Meyboom-de Jong B, Kleiverda A. Mifepristone followed by home administration of buccal misoprostol for medical abortion up to 70 days of amenorrhoea in a general practice in Curaçao. Eur J Contracept Reprod Health Care 2011;16:61–6.
   PubMed Web of Science ®Google Scholar
• Raghavan S, Comendant R, Digol I, . Comparison of 400 mcg buccal and 400 mcg sublingual misoprostol after mifepristone medical abortion through 63 days’ LMP: A randomized controlled trial. Contraception 2010;82:513–9.
   PubMed Web of Science ®Google Scholar
• World Health Organisation Task Force on Post-ovulatory Methods of Fertility Regulation. Termination of pregnancy with reduced doses of mifepristone. BMJ 1993;307:532–7.
   PubMed Web of Science ®Google Scholar
• World Health Organisation Task Force on Post-ovulatory Methods of Fertility Regulation. Comparison of two doses of mifepristone in combination with misoprostol for early medical abortion: A randomised trial. BJOG 2000;107:524–30.
   PubMed Web of Science ®Google Scholar
• WHO. Frequently asked clinical questions about medical abortion. Geneva: World Health Organization 2007 Accessed 10 11 12 from: http://www.who.int/reproductivehealth/publications/unsafe_abortion/9241594845/en/
   Google Scholar
• Ukraine Ministry of Health. Clinical protocol “Comprehensive care for unwanted pregnancies” No. 1177 (2010).
   Google Scholar
• Mundle S, Elul B, Anand A, . Increasing access to safe abortion services in rural India: Experiences with medical abortion in a primary health center. Contraception 2007;76:66–70.
   PubMed Web of Science ®Google Scholar
• Coyaji K, Elul B, Krishna U, . Mifepristone-misoprostol abortion: A trial in rural and urban Maharashtra, India. Contraception 2002;66:33–40.
   PubMed Web of Science ®Google Scholar
• Tran NT, Jang MC, Choe YS, . Feasibility, efficacy, safety, and acceptability of mifepristone-misoprostol for medical abortion in the Democratic People's Republic of Korea. Int J Gynaecol Obstet 2010;109: 209–12.
   PubMed Web of Science ®Google Scholar
• Clark W, Bracken H, Tanenhaus J, . Alternatives to a routine follow-up visit for early medical abortion. Obstet Gynecol 2010;115:264–72.
   PubMed Web of Science ®Google Scholar
• Blum J, Shochet T, Lynd K, . Can at-home semi-quantitative pregnancy tests serve as a replacement for clinical follow-up of medical abortion: A United States study. Contraception 2012;86:757–62.
   PubMed Web of Science ®Google Scholar